|
|
|
About the Presenter
S. Nassir Ghaemi, M.D., M.P.H., is Professor of Psychiatry at Tufts University School of Medicine and Director of the Mood Disorders Program at Tufts Medical Center. Dr. Ghaemi is widely known for his research, writing, and teaching in psychopharmacology, mood disorders, and philosophy of psychiatry. He is the author of over 100 scientific papers, and several books, including Mood Disorders: A Practical Guide, A Clinician’s Guide to Statistics and Epidemiology in Mental Health: Measuring Truth and Uncertainty, The Concepts of Psychiatry: A Pluralistic Approach to the Mind and Mental Illness, and The Rise and Fall of the Biopsychosocial Model: Reconciling Art and Science in Psychiatry. He serves on many editorial boards, including that of the Journal of Affective Disorders.
Symposium Description
This symposium will provide participants with an unique opportunity to learn the principles and practice of contemporary psychopharmacology. Participants will learn to 1) apply key statistical concepts to be able to understand psychopharmacology research; 2) comprehend the importance of nosology for psychopharmacology and take a critical approach to the basis of psychiatric diagnosis in DSM-IV; 3) utilize the pharmacology of the major psychotropic drug classes; 4) describe the research evidence base for the clinical use of psychotropic drugs in the major mental illnesses; and 5) appreciate conceptual assumptions in the practice of psychopharmacology, including values and beliefs, and recognize and critique one’s own assumptions.
SYMPOSIUM SCHEDULE
Monday
-
Principles of Psychopharmacology: Neuroscience, statistics, and nosology: Neurobiology fundamentals: Neuroanatomy, pharmacokinetics and pharmacodynamics of drug action
Statistical principles for interpreting psychopharmacology research studies
Towards a Hippocratic psychopharmacology
DSM-V: The past and future of psychiatric nosology
Tuesday
Research evidence for neuroleptic use in psychotic disorders and in mood disorders
Research evidence regarding side effects and risks
Clinical practice with neuroleptics
Wednesday
Research evidence for mood stabilizer use in mood disorders
Research evidence regarding side effects and risks
Clinical practice with mood stabilizers
Thursday
Research evidence for antidepressant use in mood disorders
Research evidence for amphetamine use in cognitive disorders
Research evidence regarding side effects and risks
Clinical practice with antidepressants and amphetamines
Friday
Why antidepressants are not antidepressants; Risks and benefits of amphetamines
Method-based psychiatry – A new approach
Open discussion |
|
|
|
